Lance A. Liotta
Liotta, L.A.
Liotta, Lance A.
Liotta, L. A. (Lance A.)
VIAF ID: 19749807 (Personal)
Permalink: http://viaf.org/viaf/19749807
Preferred Forms
- 100 0 _ ‡a Lance A. Liotta
- 200 _ | ‡a Liotta ‡b Lance A.
-
- 100 1 _ ‡a Liotta, L. A. ‡q (Lance A.)
- 100 1 _ ‡a Liotta, L. A. ‡q (Lance A.)
-
-
- 100 1 _ ‡a Liotta, L.A.
-
- 100 1 _ ‡a Liotta, Lance A.
-
-
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Biochemistry and molecular genetics of cancer metastasis : proceedings of the Symposium on Biochemistry and Molecular Genetics of Cancer Metastasis, Bethesda, Maryland, March 18-20, 1985 | |
Boundaries between promotion and progression during carcinogenesis | |
Cancer metastasis : experimental and clinical strategies : proceedings of a symposium held in Kalamazoo, Michigan, September 15-17, 1985 | |
Genetic mechanisms in carcinogenesis and tumor progression : proceedings of a Genentech-UCLA symposium held at Keystone, Colorado, January 21-27, 1989 | |
Influence of tumor development on the host | |
Molecular profiling : methods and protocols | |
Putting the "bio" back into biomarkers: orienting proteomic discovery toward biology and away from the measurement platform. | |
Quantitative cell signalling analysis reveals down-regulation of MAPK pathway activation in colorectal cancer | |
Quantum dots for biomedical applications | |
Rapamycin modulation of p70 S6 kinase signaling inhibits Rift Valley fever virus pathogenesis | |
Rapid Detection of Biological and Chemical Threat Agents Using Physical Chemistry, Active Detection, and Computational Analysis | |
Reactive oxygen species activate NFκB (p65) and p53 and induce apoptosis in RVFV infected liver cells | |
Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society | |
Regulatory approval pathways for molecular diagnostic technology | |
Retinal pigment epithelium (RPE) exosomes contain signaling phosphoproteins affected by oxidative stress | |
Retroviral infection of human neurospheres and use of stem Cell EVs to repair cellular damage | |
Reverse-Phase Microarray Analysis Reveals Novel Targets in Lymph Nodes of Bacillus anthracis Spore-Challenged Mice | |
Reverse-phase phosphoproteome analysis of signaling pathways induced by Rift valley fever virus in human small airway epithelial cells | |
Reverse-phase protein microarrays: application to biomarker discovery and translational medicine. | |
Reverse phase protein microarrays for monitoring biological responses | |
Reverse-phase protein microarrays (RPPA) as a diagnostic and therapeutic guide in multidrug resistant leukemia | |
Role of km23-1 in RhoA/actin-based cell migration | |
Role of proteomics in personalized medicine | |
RPPA: Origins, Transition to a Validated Clinical Research Tool, and Next Generations of the Technology | |
Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma | |
Secreted neutral metalloproteases of Bacillus anthracis as candidate pathogenic factors | |
Selective binding and enrichment for low-molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles | |
Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold | |
Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml | |
Serum proteomics in cancer diagnosis and management. | |
Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients | |
Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection | |
Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray | |
Site-directed mutations in the tumor-associated cytokine, autotaxin, eliminate nucleotide phosphodiesterase, lysophospholipase D, and motogenic activities | |
Small business development for molecular diagnostics. | |
Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation | |
The spectra count label-free quantitation in cancer proteomics. | |
Stratification of clear cell renal cell carcinoma by signaling pathway analysis | |
Stromal therapy: the next step in ovarian cancer treatment | |
Stromal TRIM28-associated signaling pathway modulation within the colorectal cancer microenvironment. | |
STUDENTJAMA. Molecular technologies for personalized cancer management. | |
Students who demonstrate strong talent and interest in STEM are initially attracted to STEM through extracurricular experiences | |
Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis | |
The Sustained Induction of c-MYC Drives Nab-Paclitaxel Resistance in Primary Pancreatic Ductal Carcinoma Cells | |
Synthesis and characterization of hydrogel particles containing Cibacron Blue F3G-A | |
Systems analysis of the NCI-60 cancer cell lines by alignment of protein pathway activation modules with "-OMIC" data fields and therapeutic response signatures | |
TB-04PROTEOMICS ANALYSIS OF CEREBROSPINAL FLUID (CSF) FROM CHILDREN WITH CNS TUMOURS IDENTIFY CANDIDATE PROTEINS RELATING TO TUMOUR METASTATIC SPREAD. | |
Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays | |
Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability | |
The topological requirements for robust perfect adaptation in networks of any size. | |
Toward detection of toxoplasmosis from urine in mice using hydro-gel nanoparticles concentration and parallel reaction monitoring mass spectrometry | |
Toxicoproteomics: serum proteomic pattern diagnostics for early detection of drug induced cardiac toxicities and cardioprotection | |
Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. | |
Trapping radioactive carbon dioxide during cellular metabolic assays under standard culture conditions: description of a unique gas-capturing device | |
Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ | |
Tumor invasion and metastasis, 1982 (a.e.) | |
Tumor vascular proteins as biomarkers in ovarian cancer | |
Unlocking bone for proteomic analysis and FISH | |
Unlocking the secrets to protein-protein interface drug targets using structural mass spectrometry techniques | |
Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity. | |
Use of a novel chagas urine nanoparticle test (chunap) for diagnosis of congenital chagas disease | |
The use of hydrogel microparticles to sequester and concentrate bacterial antigens in a urine test for Lyme disease. | |
Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment | |
The use of Nanotrap particles for biodefense and emerging infectious disease diagnostics | |
The use of Nanotrap particles technology in capturing HIV-1 virions and viral proteins from infected cells | |
Use of proteomic analysis to monitor responses to biological therapies | |
Use of proteomic patterns in serum to identify ovarian cancer | |
Use of proteomic patterns to screen for gastrointestinal malignancies. | |
Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. | |
Use of Stem Cell Extracellular Vesicles as a "Holistic" Approach to CNS Repair | |
Utility of reverse phase protein arrays: applications to signalling pathways and human body arrays | |
Utilization of Proteomic Technologies for Precision Oncology Applications | |
The Warburg Effect and Mass Spectrometry-based Proteomic Analysis | |
What is the malignant nature of human ductal carcinoma in situ? | |
Whole proteome analysis of mouse lymph nodes in cutaneous anthrax |